Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
Public ClinicalTrials.gov record NCT00102921. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pilot, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety Clinical Activity of CCX282-B in Patients With Moderate to Severe Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to investigate the effects of an investigational medication, called CCX282-B, on safety and on the some of the symptoms of Crohn's Disease in patients who are experiencing an active flare-up of moderate to severe Crohn's Disease.
Study identification
- NCT ID
- NCT00102921
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2004
- Primary completion
- Not listed
- Completion
- Nov 30, 2005
- Last update posted
- Mar 5, 2025
2004 – 2005
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Rocky Mountain Clincal Research | Golden | Colorado | 80104 | — |
| Arapahoe Gastroenterology | Littleton | Colorado | 80120 | — |
| Atlanta Gastroenterology Associates | Atlanta | Georgia | 30342 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | — | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| Long Island Clinical Research Associates, LLP | Great Neck | New York | 11021 | — |
| Wake Forest Research | Raleigh | North Carolina | 27612 | — |
| University Hospitals of Cleveland, Div of Gastroenterology | Cleveland | Ohio | 44106-5066 | — |
| Digestive Disease Clinic | Jackson | Tennessee | 38305 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
| Center for Colon Rectal Disease | Salt Lake City | Utah | 84124 | — |
| University of Virginia Health System, Digestive Health Center of Excellence | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00102921, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 5, 2025 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00102921 live on ClinicalTrials.gov.